Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19 Pt 2
pubmed:dateCreated
2005-10-5
pubmed:abstractText
Met, an oncogene product and receptor tyrosine kinase, is a keystone molecule for malignant progression in solid human tumors. We are developing Met-directed imaging and therapeutic agents, including anti-Met monoclonal antibodies (MetSeek). In this study, we compared two antibodies, Met5 and Met3, for nuclear imaging of human and canine Met-expressing tumor xenografts in nude mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7064s-7069s
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16203803-Animals, pubmed-meshheading:16203803-Antibodies, Monoclonal, pubmed-meshheading:16203803-Dogs, pubmed-meshheading:16203803-Female, pubmed-meshheading:16203803-Humans, pubmed-meshheading:16203803-Image Processing, Computer-Assisted, pubmed-meshheading:16203803-Male, pubmed-meshheading:16203803-Mice, pubmed-meshheading:16203803-Mice, Nude, pubmed-meshheading:16203803-Nasopharyngeal Neoplasms, pubmed-meshheading:16203803-Neoplasm Transplantation, pubmed-meshheading:16203803-Neoplasms, pubmed-meshheading:16203803-Prostatic Neoplasms, pubmed-meshheading:16203803-Proto-Oncogene Proteins c-met, pubmed-meshheading:16203803-RNA, Small Interfering, pubmed-meshheading:16203803-Radioimmunotherapy, pubmed-meshheading:16203803-Radionuclide Imaging, pubmed-meshheading:16203803-Time Factors
pubmed:year
2005
pubmed:articleTitle
Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).
pubmed:affiliation
Van Andel Research Institute, Grand Rapids, Michigan 49503, USA. Rick.Hay@vai.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't